Skip to main content

Table 1 Characteristics of the hip fracture and medical delirium patients

From: CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau

 

Hip fracture cohort

Medical delirium

All

No delirium

Delirium

All

Incident

Prevalent

Medical

PATIENTS WITHOUT DEMENTIA

N

59

44

15

7

8

17

Age (years)

84 (10)

84 (16)

85 (7)

86 (11)

85 (7)

66 (16)

Gender

 Male

17

11

6

3

3

10

 Female

42

33

9

4

5

7

Time to surgery (h)*

23 (17)

23 (17)

27 (15)

22 (19)

30 (14)

CSF sTREM2 ng/ml

7.8 (5.7)

7.4 (5)

11.1(11)

11.6 (5)

7.8 (15)

5.6 (8)

CSF biomarkers

N

57

44

13

5

8

 

CSF Aβ42 (pg/ml)

446 (367)

479 (414)

283 (224)

283 (232)

295 (253)

CSF t-tau (pg/ml)

369 (276)

356 (198)

564 (638)

564 (369)

587 (795)

CSF p-tau (pg/ml)

57(35)

54 (33)

78 (68)

78 (19)

88 (89)

CSF Aβ42 cut-off (< 530 pg/ml)

 Below

37

26

11

4

7

 Above

20

18

2

1

1

CSF p-tau cut-off (≥ 60 pg/ml)

     

 Above

26

17

9

4

5

 Below

31

27

4

1

3

CSF t-tau cut-off (> 350 pg/ml)

     

 Above

32

23

9

5

4

 Below

25

21

4

4

PATIENTS WITH DEMENTIA

N

61

10

50

13

33

9

Age (years)

86 (9)

86.5 (17)

85(9)

87 (8)

85 (8)

71(23)

Gender

 Male

16

1

15

5

8

6

 Female

45

9

35

8

25

3

Time to surgery (h)*

26 (28)

27 (16)

26(31)

18(19)

38 (24)

CSF sTREM2 ng/ml

7.0 (7.8)

9.2 (16)

7.3 (7)

6.1 (10)

8.5 (8)

6.9(6.7)

CSF biomarkers, N

60

9

50

13

33

 

CSF Aβ42 (pg/ml)

265 (166)

317 (290)

258 (172)

268 (219)

269 (174)

CSF t-tau (pg/ml)

408 (379)

441 (503)

408 (366)

385 (293)

407 (329)

CSF p-tau (pg/ml

55 (41)

58 (57)

55 (35)

55 (47)

55 (31)

CSF Aβ42 cut-off (< 530 pg/ml)

 Below

55

7

47

11

1

 Above

5

2

3

2

32

CSF p-tau cut-off (≥ 60 pg/ml)

     

 Above

24

4

20

5

13

 Below

36

5

30

8

20

CSF t-tau cut-off (> 350 pg/ml)

     

 Above

38

5

33

8

22

 Below

22

4

17

5

11

  1. Data are presented as median and interquartile range (IQR), waiting time for surgery. Aβ42, amyloid beta 1–42; t-tau, total-tau; p-tau, phosphorylated tau; sTREM2, soluble triggering receptor expressed on myeloid cells
  2. *Time to surgery, hours from hospital admission to surgery (onset of anesthesia) and CSF sampling